Broad Institute Uses AI to Design New Antibiotics and Predict Drug Toxicity
β’ The Broad Institute is leveraging artificial intelligence to accelerate drug discovery, designing new antibiotics and predicting drug toxicity with greater accuracy than traditional methods. β’ The AI systems are also being applied to identify specific genes, molecules, and cells that might serve as therapeutic targets for disease treatment. β’ This computational approach promises to dramatically speed up the drug development pipeline and reduce the cost and time required to bring new medications to patients.
Read original Β· broadinstitute.org







